New York State Common Retirement Fund’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.12M | Buy |
67,173
+1,002
| +2% | +$31.7K | ﹤0.01% | 1384 |
|
|
2025
Q1 | $2.2M | Buy |
66,171
+4,293
| +7% | +$142K | ﹤0.01% | 1342 |
|
|
2024
Q4 | $2.13M | Buy |
61,878
+14,406
| +30% | +$496K | ﹤0.01% | 1396 |
|
|
2024
Q3 | $1.9M | Buy |
47,472
+29,800
| +169% | +$1.19M | ﹤0.01% | 1422 |
|
|
2024
Q2 | $533K | Buy |
17,672
+4,114
| +30% | +$124K | ﹤0.01% | 2023 |
|
|
2024
Q1 | $455K | Sell |
13,558
-38
| -0.3% | -$1.28K | ﹤0.01% | 2120 |
|
|
2023
Q4 | $439K | Sell |
13,596
-51
| -0.4% | -$1.65K | ﹤0.01% | 2147 |
|
|
2023
Q3 | $447K | Buy |
13,647
+144
| +1% | +$4.72K | ﹤0.01% | 2105 |
|
|
2023
Q2 | $475K | Sell |
13,503
-138,142
| -91% | -$4.86M | ﹤0.01% | 2118 |
|
|
2023
Q1 | $4.95M | Sell |
151,645
-53,905
| -26% | -$1.76M | 0.01% | 1168 |
|
|
2022
Q4 | $11.3M | Buy |
205,550
+21,609
| +12% | +$1.19M | 0.02% | 814 |
|
|
2022
Q3 | $8.15M | Buy |
183,941
+81,565
| +80% | +$3.61M | 0.01% | 939 |
|
|
2022
Q2 | $4.99M | Buy |
102,376
+84,850
| +484% | +$4.14M | 0.01% | 1196 |
|
|
2022
Q1 | $853K | Buy |
17,526
+1,438
| +9% | +$70K | ﹤0.01% | 2186 |
|
|
2021
Q4 | $686K | Sell |
16,088
-43
| -0.3% | -$1.83K | ﹤0.01% | 2273 |
|
|
2021
Q3 | $618K | Sell |
16,131
-3,120
| -16% | -$120K | ﹤0.01% | 2352 |
|
|
2021
Q2 | $543K | Buy |
19,251
+12,851
| +201% | +$362K | ﹤0.01% | 2558 |
|
|
2021
Q1 | $211K | Buy |
6,400
+2,900
| +83% | +$95.6K | ﹤0.01% | 2811 |
|
|
2020
Q4 | $127K | Buy |
+3,500
| New | +$127K | ﹤0.01% | 2927 |
|